Omics, MDx Shares Cool Down in July; PacBio, Cepheid, GenMark Shares Retreat 20+ Percent | GenomeWeb

NEW YORK (GenomeWeb) – In July the stocks of companies operating in the omics research tools and molecular diagnostics spaces returned almost all of their gains from June as the GenomeWeb Daily News Index dropped 5 percent month over month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.